Glemser Launches Life Science Compliance IT Blog

Experts in Content and Quality Management offer insights that support regulatory operations, IT, QC, and R&D

Bethlehem, PA / July 20, 2016 / Glemser Technologies, a provider of content and quality management solutions, has introduced a blog that serves as an educational resource for Life Science professionals in regulatory operations and IT—sharing experiences to help companies better develop and commercialize medications for improved patient outcomes.

Topics covered in the new blog include: impacts of regulatory issues on existing systems such as Identification of Medicinal Products (IDMP); consolidation from mergers and acquisitions; emerging or evolving technologies including EMC Documentum, TrackWise, and others; case studies that overcome challenges and demonstrate quantitative ROI; and informed observations from industry conferences and user groups.

“Our viewpoints are based on 30 years of experience developing and applying innovative software and services to meet critical business and compliance needs in life sciences,” says Raymond Glemser, President at Glemser Technologies. “We believe our new blog will become a trusted resource for professionals in regulatory compliance, IT, quality control, and research and development.”

Readers can compare their strategies to the latest best practices, share insights directly to their email inbox, suggest topics, and submit guest posts.

Recent blog posts include:

  • Regulatory Changes on the Horizon: Global Impact of the IDMP
  • By the Book: Documentation Requirements in TrackWise
  • All Together Now: The Benefits of Playing in a TrackWise Sandbox

Visit Glemser’s Blog at


About Glemser Technologies

Since 1987, Glemser Technologies has helped Life Science companies across North America and Europe solve their most pressing challenges in quality, compliance and efficiency through innovative software and consulting. Our suite of fully customizable content and quality management solutions allow companies to better develop and commercialize medications to ensure better patient outcomes while lowering their total cost of ownership. Headquartered in Bethlehem, Pennsylvania with offices in Dublin, Ireland.